Clinical Report: mRNA Expands into Fertility Medicine

Overview

Researchers in Japan have shown that mRNA therapy can restore fertility in a genetic mouse model of male infertility. This approach offers a potential new direction for reproductive medicine, avoiding permanent gene editing.

Background

Male infertility is a significant clinical issue, often resulting from disrupted communication between germ cells and Sertoli cells, leading to meiotic arrest. Current assisted reproductive technologies are limited for patients with severe spermatogenic defects. The exploration of mRNA therapy presents a novel, non-integrating approach to potentially restore fertility.

Data Highlights

The study demonstrated that therapeutic mRNA delivered to Sertoli cells can restart sperm development in genetically infertile mice, leading to the production of haploid spermatids.

Key Findings

• Therapeutic mRNA can be delivered directly into the testes to restart sperm development.
• Injected mRNA was successfully taken up by Sertoli cells, leading to detectable protein expression.
• Two months post-treatment, renewed spermatogenesis was observed in many seminiferous tubules.
• Although natural fertility was not fully restored, the approach enabled the birth of offspring via assisted reproductive techniques.
• mRNA therapy presents a safer alternative to DNA-based gene therapy due to its transient nature.

Clinical Implications

The findings suggest that mRNA therapy could be a viable option for treating male infertility, particularly in cases where traditional methods are ineffective. Clinicians should consider the potential of mRNA-based interventions as part of future fertility treatment strategies.

Conclusion

This research highlights the promising role of mRNA therapy in reproductive medicine, paving the way for new treatments for male infertility that do not involve permanent genetic modifications.

Related Resources & Content

1. The ASCO Post, EMR-Integrated Messaging Drastically Increases Cancer-Related Fertility Preservation Referrals, 2025 -- https://ascopost.com/news/june-2025/emr-integrated-messaging-drastically-increases-cancer-related-fertility-preservation-referrals
2. The ASCO Post, Fertility Preservation Suggested With Triptorelin in Long-Term Study, 2014 -- https://ascopost.com/issues/october-15-2014/fertility-preservation-suggested-with-triptorelin-in-long-term-study
3. The Journal of Clinical Endocrinology & Metabolism, Modelling Follicular Growth During Ovarian Stimulation Using Agent-based Artificial Intelligence -- https://academic.oup.com/jcem/advance-article/doi/10.1210/clinem/dgaf539/8268247
4. WHO, Guideline for the prevention, diagnosis and treatment of infertility -- https://www.who.int/publications/i/item/9789240115774
5. the medicine maker — Building the Future of RNA Manufacturing
6. Sperm and offspring production in a nonobstructive azoospermia mouse model via testicular mRNA delivery using lipid nanoparticles
7. Guideline for the prevention, diagnosis and treatment of infertility